Cargando…
Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
Introduction. Hepatotoxicity is a concern in HIV/hepatitis C virus (HCV) coinfected patients due to their underlying liver disease. This study assessed the incidence of hepatotoxicity in HIV/HCV co-infected patients in two outpatient infectious diseases clinics. Methods. HIV/HCV co-infected adults w...
Autores principales: | Heil, Emily L., Townsend, Mary L., Shipp, Kenneth, Clarke, Amy, Johnson, Melissa D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065809/ https://www.ncbi.nlm.nih.gov/pubmed/21490905 http://dx.doi.org/10.1155/2010/856542 |
Ejemplares similares
-
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012) -
Hepatic steatosis in HIV-HCV coinfected patients receiving
antiretroviral therapy is associated with HCV-related factors but not
antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013) -
Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009) -
HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
por: Vogel, Martin, et al.
Publicado: (2009) -
The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)